Efavirenz for the Treatment of Creutzfeldt-Jakob Disease

NCT07482085 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

246

Enrollment

OTHER

Sponsor class

Conditions

Creutzfeldt-Jakob Disease

Interventions

DRUG: Efavirenz
DRUG: Placebo

Sponsor

Xuanwu Hospital, Beijing